Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

How preventing RSV, a respiratory virus especially harmful to babies, pays off New prevention measures for RSV have led to a major drop in hospitalizations among infants, according to a new CDC study.

RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived New tools may have reduced cases of severe respiratory illness, CDC says A pediatric visit in Denver.

The recommendations go to the CDC, and it’s unclear how quickly the agency may act A 3D rendering of the respiratory syncytial virus. NIAID ...